Clinical Trials
2 trialsNCT01283048 2016-09-21
Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma
Dana-Farber Cancer Institute
Phase 1 Completed
NCT00421512 2008-11-11
A Phase I Study of Bevacizumab and Sunitinib in Metastatic Renal Cell Carcinoma Patients
Memorial Sloan Kettering Cancer Center
Phase 1 Completed